Israeli Pharma Firm Pays $519 Million to Settle FCPA Charges

Posted 1/9/17

Israeli firm Teva Pharmaceutical Industries, the world's largest generic drug manufacturer, and its wholly owned Russian subsidiary, Teva LLC (Teva Russia), agreed Dec. 22, 2016, to pay $519 million …

This item is available in full to subscribers.

Please log in to continue

Log in